Konferenzen  >  Biowissenschaften  >  Biotechnologie

Uventia Global

The assessment of extractables and leachables is a critical step in the biopharmaceutical development process. The interactions between pharmaceutical products and drug delivery systems, bioprocess manufacturing systems, and container closing systems are of special concern for regulatory bodies. Therefore, it is necessary to carefully examine the migration of mobile molecules from the materials and components utilized in the production and storage of pharmaceuticals. We organize a virtual conference to facilitate discussion on the most recent analytical techniques, regulatory updates, risk-based E&L programs, chemical characterization and toxicological risk assessment among scientists, toxicologists and E&L managers. We also cover ISO 10993-18, medical device materials, analytical and safety thresholds and customized systems for different product types.

Email: yuliia.terletska@uventia.com

Updated regulatory guidelines for E&L testing, How to implement effective E&L study designs, Risk assessing extractables and leachables, Toxicological Risk Assessment, Single Use Systems (SUS), drug products, X-ray vs. gamma, rubber closures, E&L testing for medical devices, bioprocess equipment, Testing for E&L in packaging materials, E&L assessment of cell and gene therapies

Pharmakologie und Arzneimittelentwicklung,    Biochemie und Medizinische Chemie, Toxikologie

ComplianceOnline

US FDA statements and actions indicate the initial and purpose of Part 11 "Add-on" inspections are being extended beyond what was to be a short term review of industry's response to Part 11. Using the field tested techniques presented in this webinar, an internal and/or supplier audit can provide much the same early warnings as a real FDA compliance CGMP audit. This webinar will provide test scripts and rationale for a "model" for company internal and supplier audits.

Event Manager;     Tel.: [+1-888-717-2436];     Email: sshastry@complianceonline.com

Audits for CGMP Compliance, Old QSR, New QMSR, Combo Products, Pharma and Dietary Supplements, Internal and Supplier Audits, Virtual Audits, Layered Process Audits, ISO 13485, ICH Q7, ISO 9001 GMP, QMS, CAPA Requirements, Root Cause Analysis Tools, Six Sigma, Problem Solving Tools, Methodology, FDA Requirements, Management Responsibility

CHI

OPT Congress is the premier conference for scientists and clinicians involved in discovering and developing oligonucleotides as therapeutics. For 2025 we are delighted to expand our content and offer a new conference program dedicated to emerging oligo modalities to showcase where the science is heading in the very near future and share cutting-edge research and technologies with community. Now in its 10th year, this unique event brings together leading chemists, biologists, toxicologists, CMC experts, regulatory specialists and technology providers to discuss advances in next-generation oligonucleotides and mRNA therapeutics. In addition to 2 days of inspiring keynotes, interactive discussions and more than 95 scientific presentations, we deliver in-depth short courses to further add to the learning opportunities while you are on site with us. We look forward to having you join us for this important scientific and networking event, that offers robust and customizable programming.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Oxford Global

Join NextGen Biomed 2025 to connect with 1,000+ experts in Proteins, Peptides, Oligonucleotides, Vaccines, Immunotherapy & Sustainability. Discover breakthroughs, attend panels, and network to drive life-saving innovation.

Brand and Content Manager;     Email: c.donohoe@oxfordglobal.com

Vaccines, Peptides, Oligonucleotides, Antibodies, Biomedicine, Immunotherapy, Immuno-oncology, ACD's, Sustainability, Proteins,

Genomforschung und Bioinformatik,    Systembiologie und mathematische Biologie

CHI

Bioprocessing Summit Europe brings together 750+ upstream, downstream, bioproduction, and analytical professionals from industry and academia to advance the manufacture, quality, and control of next generation biologics and genetic therapies. This 3-day, 14-track meeting has quickly become a premier event in the European bioprocessing calendar and focuses on the latest innovations in bioprocess R&D as well as the practical solutions to enhance efficiency, speed and cost in biomanufacturing. New for 2025, we are excited to add a new conference stream on process modelling and digitalization, alongside expanded content on ML/AI, advanced process control, developability, cell culture, downstream processing, analytics, and the latest in cell, gene, and RNA therapies.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Doctoral Students’ and Non-Doctoral Research Fellows’ Committee (CADBI) of Health Sciences Research Centre (CICS-UBI, in fusion process to become RISE-Health)

HSRCongress is a biannual three-day congress dedicated to basic, industrial and clinical biomedical research organized by Doctoral Students’ and Non-Doctoral Research Fellows’ Committee (CADBI) of Health Sciences Research Centre (CICS-UBI, in fusion process to become RISE-Health). This event will highlight the latest research and bring together national and international biomedical researchers and stakeholders, encouraging the development of new collaborations and new science-driven questions. Also, given its multidisciplinary, HSRCongress is a unique opportunity for young researchers to take their first steps in the scientific community.

Organizing Committee;     Email: hsrcongress@fcsaude.ubi.pt

Topic 1 – Identification of molecular mechanisms underlying disease onset and progression Topic 2 – Identification of therapeutic targets Topic 3 – Development of novel drugs, biopharmaceuticals and biomaterials with therapeutic applications Topic 4 – Development and/or improvement of delivery systems Topic 5 – Development and/or improvement of diagnosis, prognosis and monitoring tools

Medizintechnik,    Immunologie und Allergie

Oxford Global

Advancing therapeutic Innovation through Multi-Omic Analysis – Celebrating its 11th Year. Join us at NextGen Omics & Spatial Biology US 2025, a premier event celebrating its 11th year of advancing therapeutic innovation through multi-omic analysis. This gathering brings together over 1,000 senior experts in multi-omics and spatial analysis from leading pharmaceutical, biotech, and life sciences companies, creating a vibrant platform for collaboration and innovation.

Tel.: [01865 248 455];     Email: k.thande@oxfordglobal.com

Built with industry experts in-mind, the conference programme highlights: • Hear from and meet with key innovators in genomics • Discuss digital PCR & Liquid Biopsies. • Join a series of workshops, panel discussions and roundtables • Advance your understanding of emerging single cell technologies • Take a deep dive into data harmonisation, integration and analysis. Take a look here and discover the NextGen Omics & Spatial Biology US 2025 agenda.

BioForum

CEBioForum, a networking conference held since 20 years, brings together biotech innovators, business and government leaders. Event includes panel sessions, company presentations from Poland & Europe and arranging b2b meetings in a dedicated application.

Tel.: [+48 607 490 642];     Email: kontakt@cebioforum.com

personalized medicine and longevity, biotech and sustainable development, project development, investments in biotech companies, barriers to the development of biotech business in the context of the Biotech Act

EBD Group

Engage with the largest network of potential partners to accelerate your cross-border strategies and expand your reach into the China market.

Tel.: [8018919874];     Email: christopher.chang@informa.com

partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, China, life science

Singularity University

In May 2025 in San Diego, we will host experts, innovators, and executives from diverse industries to explore and shape the future of biotech-driven innovation.

Singularity Programs Team;     Tel.: [1-650-200-3434];     Email: programs@su.org

AI, Bio-informed innovation, Wast-to-value, Micro-bio Workforce, Digital Biology, Bio-Mining, Bio-energy, Bio-Manufacturing, Future of Food

Systembiologie und mathematische Biologie,    Genomforschung und Bioinformatik

CHI

The 2025 PEGS Boston Summit is set to build on the remarkable success of previous years, continuing its legacy as the premier event for biologics and protein engineering. Bringing together a global community of experts, innovators, and leaders in the field, the Summit will offer cutting-edge insights into the latest advances in drug development, protein and antibody engineering, immunotherapy, radiotherapy, and AI/ML-driven biologics research. With over 300 presentations, breakout sessions, and interactive seminars, attendees will have unparalleled opportunities to network, learn, and engage in meaningful collaborations. The exhibit hall will once again feature top product and service providers, creating a gathering space for discovery, innovation, and fun. Join us at the PEGS Boston Summit to be part of the next wave of breakthroughs shaping the future of biologics.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Conplus meetings

This conference offers a unique platform for networking, allowing attendees to connect with peers, engage with leading experts, and explore new collaborative opportunities. Beyond the academic content, attendees will have the chance to experience the cultural and historical charm of Amsterdam. We warmly invite you to join us in Amsterdam for Biotech2025, which promises to be an intellectually stimulating event as well as an opportunity to enjoy the beauty and culture of this remarkable city. We look forward to welcoming you to what promises to be an exciting and inspiring event.

Tel.: [09063687428];     Email: biotech2025@conplusmeeting.com

Biotechnology, Genomic Technologies, Proteomics, Metabolomics, Systems Biology, Synthetic Biology, Bioengineering, Medical Devices, Bioinformatics Data Science, Environmental Biotechnology, Industrial Biotechnology, Bioprocessing, Medical Biotechnology, Therapeutics, Agricultural Biotechnology, Microbial Biotechnology, Plant Biotechnology, Marine Biotechnology, Nanobiotechnology, Pharmaceutical Biotechnology, Bioinformatics, Phylogenetics, Personalized Medicine, Precision Healthcare, Biotech Entrepreneurship, etc.

Chemical engineering, biotechnology and bioprocessing are the key to providing innovative solutions for food supply, mobility, energy, health and well-being while striving for a sustainable economy. At ECCE 15 & ECAB 8, scientists from industry, universities and research institutions from Europe and beyond will meet in Lisbon to discuss the latest research and industrial applications in all fields of chemistry, process engineering, biotechnology and related fields. This year’s conference will be held in conjunction with the 3rd CIBIQ - Iberoamerican Congress on Chemical Engineering.